Literature DB >> 1686207

The effects of idazoxan and other alpha 2-adrenoceptor antagonists on food and water intake in the rat.

H C Jackson1, I J Griffin, D J Nutt.   

Abstract

1. Idazoxan (1, 3, 10 mg kg-1, i.p.) produced a significant increase in food and water intake in freely feeding rats during the daylight phase. 2. The more selective and specific alpha 2-adrenoceptor antagonists, RX811059 (0.3, 1, 3 mg kg-1, i.p.) and RX821002 (0.3, 1, 3 mg kg-1, i.p.), did not produce hyperphagia in rats, however, the highest dose produced a significant increase in water intake. 3. The peripherally acting alpha 2-adrenoceptor antagonist, L-659,066 (1, 3, 10 mg kg-1, i.p.), did not affect food intake in the 4 h following injection, but the highest dose (10 mg kg-1), produced a large increase in water intake. 4. These results indicate that alpha 2-adrenoceptor antagonists may increase water intake by a peripherally mediated mechanism. 5. The lack of effect RX811059 and RX821002 on food intake contrasts with the large dose-related increases induced by idazoxan and suggests that the hyperphagic effects of idazoxan are not due to alpha 2-adrenoceptor blockade but may instead reflect its affinity for a non-adrenoceptor site, a property not shared by the other alpha 2-antagonists.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686207      PMCID: PMC1908278          DOI: 10.1111/j.1476-5381.1991.tb12416.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  Behavioral evidence for beta-adrenoceptor subsensitivity after subacute antidepressant/alpha 2-adrenoceptor antagonist treatment.

Authors:  J M Goldstein; L C Knobloch-Litwin; J B Malick
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-06       Impact factor: 3.000

2.  [3H]RX821002: a new tool for the identification of alpha 2A-adrenoceptors.

Authors:  D Langin; M Lafontan; M R Stillings; H Paris
Journal:  Eur J Pharmacol       Date:  1989-08-11       Impact factor: 4.432

Review 3.  Are there multiple imidazoline binding sites?

Authors:  M C Michel; P A Insel
Journal:  Trends Pharmacol Sci       Date:  1989-09       Impact factor: 14.819

4.  Copious drinking and simultaneous inhibition of urine flow elicited by beta-adrenergic stimulation and contrary effect of alpha-adrenergic stimulation.

Authors:  D Lehr; J Mallow; M Krukowski
Journal:  J Pharmacol Exp Ther       Date:  1967-10       Impact factor: 4.030

5.  The influence of central noradrenergic function on 5-HT2-mediated head-twitch responses in mice: possible implications for the actions of antidepressant drugs.

Authors:  D J Heal; J Philpot; K M O'Shaughnessy; C L Davies
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

6.  Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat.

Authors:  C T Dourish; P H Hutson; G Curzon
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  The pharmacokinetics and metabolism of idazoxan in the rat.

Authors:  C J Lewis; M E Havler; M J Humphrey; J G Lloyd-Jones; M A McCleavy; N C Muir; K Waltham
Journal:  Xenobiotica       Date:  1988-05       Impact factor: 1.908

8.  A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066.

Authors:  B V Clineschmidt; D J Pettibone; V J Lotti; H B Hucker; B M Sweeney; D R Reiss; E V Lis; J R Huff; J Vacca
Journal:  J Pharmacol Exp Ther       Date:  1988-04       Impact factor: 4.030

9.  Postsynaptic alpha 2-noradrenergic receptors mediate feeding induced by paraventricular nucleus injection of norepinephrine and clonidine.

Authors:  C K Goldman; L Marino; S F Leibowitz
Journal:  Eur J Pharmacol       Date:  1985-09-10       Impact factor: 4.432

10.  Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin.

Authors:  C A Marsden; K F Martin
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

View more
  8 in total

1.  Change in the Binding of [11C]BU99008 to Imidazoline I2 Receptor Using Brain PET in Zucker Rats.

Authors:  Kazunori Kawamura; Tomoteru Yamasaki; Yiding Zhang; Hidekatsu Wakizaka; Akiko Hatori; Lin Xie; Masayuki Fujinaga; Ming-Rong Zhang
Journal:  Mol Imaging Biol       Date:  2019-02       Impact factor: 3.488

2.  Behavioural and physiological effects induced by an infusion of antisense to alpha(2D)-adrenoceptors in the rat.

Authors:  E S Robinson; D J Nutt; H C Jackson; A L Hudson
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

3.  Characterization of the discriminable stimulus produced by 2-BFI: effects of imidazoline I(2)-site ligands, MAOIs, beta-carbolines, agmatine and ibogaine.

Authors:  Nicholas MacInnes; Sheila L Handley
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

4.  Central alpha-2 adrenoceptors are responsible for a clonidine-induced cue in a rat drug discrimination paradigm.

Authors:  S Jordan; H C Jackson; D J Nutt; S L Handley
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  The effects of idazoxan and other alpha 2-adrenoceptor antagonists on urine output in the rat.

Authors:  H C Jackson; I J Griffin; S D Birkett; D J Nutt
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

6.  Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain.

Authors:  N J Mallard; A L Hudson; D J Nutt
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

7.  RS-45041-190: a selective, high-affinity ligand for I2 imidazoline receptors.

Authors:  C M Brown; A C MacKinnon; W S Redfern; A Williams; C Linton; M Stewart; R U Clague; R Clark; M Spedding
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

8.  Effects of acute selective 5-HT1, 5-HT2, 5-HT3 receptor and alpha 2 adrenoceptor blockade on naloxone-induced antinociception.

Authors:  M J Walker; C X Poulos; A D Le
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.